| Financial Year |
March 31 2023 |
| Monetary Funds |
12,204,707,432.07 |
| Held-for-trading Financial Assets |
8,678,244.96 |
| Notes Receivable |
832,024,015.14 |
| Accounts Receivable |
4,729,528,709.78 |
| Advances to Suppliers |
2,442,153,883.81 |
| Other Receivables |
352,118,228.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
106,086,572.12 |
| Dividend Receivable |
25,500,000.00 |
| Inventories |
9,788,722,917.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
22,175,740.24 |
| Other Current Assets |
155,651,724.84 |
| Total Current Assets |
32,163,881,556.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
547,081.80 |
| Long-term Equity Investment |
3,277,569,808.92 |
| Investment Properties |
70,926,531.80 |
| Fixed Assetes |
1,724,831,170.36 |
| Under-construction Projects |
50,119,007.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
323,983,528.12 |
| R&D expenses |
-- |
| Goodwill |
4,404,823.66 |
| Long-Term Deferred and Prepaid Expenses |
802,577.69 |
| Deferred Income Tax Assets |
541,906,106.56 |
| Other Non-Current Assets |
207,551,069.39 |
| Sub-Total of Non-Current Assets |
6,635,609,116.30 |
| Total Assets |
38,799,490,672.63 |
| Short-Term Loans |
56,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
246,690,399.84 |
| Accounts Payable |
4,352,540,130.47 |
| Accounts Received In Advance |
32,893,455.32 |
| Employee Compensation Payable |
1,022,466,307.76 |
| Taxes Payable |
172,119,174.04 |
| Interest Payable |
-- |
| Dividend Payable |
34,769.98 |
| Other payables |
1,206,979,139.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
30,961,195.70 |
| Other Current Liabilities |
94,787,887.54 |
| Sub-Total of Current Liabilities |
22,454,872,212.90 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
5,080,250.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
72,555,285.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
405,923,005.23 |
| Total Liabilities |
22,860,795,218.13 |
| Paid-In Capital(Or Share Stock) |
1,022,739,308.00 |
| Capital Surplus |
1,942,203,906.23 |
| Surplus Reserve |
1,320,646,920.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
8,892,941,610.21 |
| Minority Stockholder's Interest |
2,753,580,739.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,185,114,714.79 |
| Owner's Equity（Stockholder's Equity） |
15,938,695,454.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
38,799,490,672.63 |
